Table 2.

Distribution of Human Cells Among Hematopoietic Organs in Untreated and Mobilized NOD/SCID Mice

Experiment CD34+ Cells Injected per Mouse (×106) n Treatment Human Cells per mL Blood (×105) Human Cells per Femur (×106) Human Cells per Spleen (×106)
A  13  4  Control  3.1 ± 0.8 7.7 ± 1.2  nd  
  5  CY + G-CSF 0.7 ± 0.2 0.7 ± 0.2 nd  
B  15 3  Control  6.3 ± 0.9  8.7 ± 0.7 10.7 ± 2.3  
  3  G-CSF  18.5 ± 0.2 9.5 ± 0.3  9.7 ± 0.1  
C  10  2  Control 1.7 ± 0.7  0.3 ± 0.2  nd  
  G-CSF  12.5 ± 2.7* 0.8 ± 0.1  nd  
25  2  Control  20.2 ± 4.9  5.7 ± 2.8 1.7 ± 1.2  
  2  G-CSF  29.1 ± 0.8 8.5 ± 1.0  5.9 ± 1.2  
  2  G-CSF + SCF 36.0 ± 6.9  9.0 ± 0.6  5.2 ± 1.6  
E  16 3  Control  1.3 ± 1.0  3.4 ± 0.8  1.3 ± 0.3 
  4  G-CSF + SCF  1.1 ± 0.3  3.2 ± 0.9 2.6 ± 0.7 
Experiment CD34+ Cells Injected per Mouse (×106) n Treatment Human Cells per mL Blood (×105) Human Cells per Femur (×106) Human Cells per Spleen (×106)
A  13  4  Control  3.1 ± 0.8 7.7 ± 1.2  nd  
  5  CY + G-CSF 0.7 ± 0.2 0.7 ± 0.2 nd  
B  15 3  Control  6.3 ± 0.9  8.7 ± 0.7 10.7 ± 2.3  
  3  G-CSF  18.5 ± 0.2 9.5 ± 0.3  9.7 ± 0.1  
C  10  2  Control 1.7 ± 0.7  0.3 ± 0.2  nd  
  G-CSF  12.5 ± 2.7* 0.8 ± 0.1  nd  
25  2  Control  20.2 ± 4.9  5.7 ± 2.8 1.7 ± 1.2  
  2  G-CSF  29.1 ± 0.8 8.5 ± 1.0  5.9 ± 1.2  
  2  G-CSF + SCF 36.0 ± 6.9  9.0 ± 0.6  5.2 ± 1.6  
E  16 3  Control  1.3 ± 1.0  3.4 ± 0.8  1.3 ± 0.3 
  4  G-CSF + SCF  1.1 ± 0.3  3.2 ± 0.9 2.6 ± 0.7 

Distribution of the mean number (±SEM) of human cells in the bone marrow, spleen, and peripheral blood of mobilized and untreated NOD/SCID mice transplanted with mobilized human peripheral blood CD34+ cells. Experiments A through E are the same as those described in Fig 8. For treatment protocols, see legend of Fig 8. Numbers in control and treated animals have been statistically compared using the Student's t-test and the level of significance has been indicated.

*

P < .05.

P < .01.

P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal